Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Biosyngen’s IND Accepted in China for T Cell Treatment of Nasopharyngeal Cancer

publication date: Oct 3, 2022

Biosyngen said and IND for its autologous T cell therapy for relapsed/metastatic nasopharyngeal cancer was accepted for review in China. BRG01 works by genetically modifying a patient's own T cells to express the additional receptor for Epstein-Barr virus antigen recognition and T cell activation when it engages EBV+ tumor cells. Biosyngen, with dual R&D centers and GMP facilities in Singapore and China, develops first-in-class and best-in-class innovative immunotherapies for global markets. The company says it has operations in Singapore, China, Germany, Australia, France and the US. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here